TY  - CONF

T1  - Specifically targeting interleukin-13 with tralokinumab improved sleep in two phase III, randomized, double-blind, placebo-controlled trials in patients with atopic dermatitis

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2021/01/01

AU  - Silverberg JI

AU  - Barbarot S

AU  - Gooderham M

AU  - Simon JC

AU  - Simpson E

AU  - Kurbasic A

AU  - Olsen CK

AU  - Cork MJ

ED  - 

VL  - 184

IS  - 3

SP  - E64

EP  - E65

Y2  - 2024/12/22

ER  -